Top compounds associated with response to TUFM


Feature Type Standardized
Nominal ANOVA
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.43 0.01
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.079 0.01
mRNA PFI-1 GDSC1000 pan-cancer AAC 0.084 0.01
mRNA CCT018159 GDSC1000 pan-cancer AAC 0.087 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.08 0.01
mRNA alvocidib CTRPv2 pan-cancer AAC 0.12 0.01
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.099 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.081 0.02
Download CSV